Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Preferred Stock Liabilities (2020 - 2021)

Rapid Micro Biosystems (RPID) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $235.8 million as the latest value for Q2 2021.

  • Quarterly Preferred Stock Liabilities rose 60.1% to $235.8 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $235.8 million through Jun 2021, up 60.1% year-over-year, with the annual reading at $151.8 million for FY2020, N/A changed from the prior year.
  • Preferred Stock Liabilities hit $235.8 million in Q2 2021 for Rapid Micro Biosystems, up from $233.8 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $235.8 million in Q2 2021 to a low of $147.3 million in Q2 2020.